Holders — by stockHoldings — by fund
Sio Capital Management, LLC
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-09-30 · filed with the SEC up to 45 days after quarter end · CIK 0001482416
$528.5M
disclosed book value
54
positions
7.6%
largest position share
Positions, as of 2026-09-30
top 55 of 54 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | AVRANTERIS TECHNOLOGIES GLOBAL | 5.2M | $40.2M | 7.6% |
| 2 | GMEDGLOBUS MED INC | 476,109 | $35.7M | 6.7% |
| 3 | GSKGSK PLC | 671,121 | $32.3M | 6.1% |
| 4 | ICLRICON PUB LTD CO | 140,999 | $24.0M | 4.5% |
| 5 | SENSSENSEONICS HLDGS INC | 2.3M | $23.3M | 4.4% |
| 6 | MRKMERCK & CO INCPUT | 150,000 | $21.8M | 4.1% |
| 7 | MRKMERCK & CO INC | 145,485 | $21.1M | 4% |
| 8 | IDYAIDEAYA BIOSCIENCES INC | 500,117 | $19.2M | 3.6% |
| 9 | PFEPFIZER INCPUT | 600,000 | $17.1M | 3.2% |
| 10 | SLSSELLAS LIFE SCIENCES GROUP IPUT | 1.2M | $15.1M | 2.9% |
| 11 | SNYSANOFI SA | 356,182 | $14.7M | 2.8% |
| 12 | ALLOALLOGENE THERAPEUTICS INC | 9.1M | $14.6M | 2.8% |
| 13 | MMSMAXIMUS INC | 268,280 | $14.3M | 2.7% |
| 14 | RLMDRELMADA THERAPEUTICS INC | 3.6M | $13.7M | 2.6% |
| 15 | VTRSVIATRIS INC | 755,490 | $13.4M | 2.5% |
| 16 | AVAHAVEANNA HEALTHCARE HLDGS INC | 1.0M | $12.6M | 2.4% |
| 17 | REPLREPLIMUNE GROUP INC | 865,331 | $11.5M | 2.2% |
| 18 | TNGXTANGO THERAPEUTICS INC | 428,860 | $10.7M | 2% |
| 19 | ANIPANI PHARMACEUTICALS INC | 146,268 | $10.6M | 2% |
| 20 | BMRNBIOMARIN PHARMACEUTICAL INC | 174,311 | $10.5M | 2% |
| 21 | CELCCELCUITY INC | 126,339 | $10.0M | 1.9% |
| 22 | AZNASTRAZENECA PLC | 61,848 | $10.0M | 1.9% |
| 23 | RAPPRAPPORT THERAPEUTICS INC | 291,231 | $9.8M | 1.9% |
| 24 | VIRVIR BIOTECHNOLOGY INC | 873,375 | $9.8M | 1.8% |
| 25 | CITHE CIGNA GROUP | 33,935 | $9.2M | 1.7% |
| 26 | COOCOOPER COS INC | 158,053 | $8.9M | 1.7% |
| 27 | LQDALIQUIDIA CORPORATION | 282,000 | $8.5M | 1.6% |
| 28 | HELPCYBIN INC | 561,289 | $6.9M | 1.3% |
| 29 | TARAPROTARA THERAPEUTICS INC | 2.0M | $6.1M | 1.1% |
| 30 | PMVPPMV PHARMACEUTICALS INC | 3.6M | $6.1M | 1.1% |
| 31 | AQSTAQUESTIVE THERAPEUTICS INC | 1.3M | $5.9M | 1.1% |
| 32 | PTCTPTC THERAPEUTICS INC | 82,900 | $5.4M | 1% |
| 33 | CRBPCORBUS PHARMACEUTICALS HLDGS | 766,364 | $5.2M | 1% |
| 34 | RNAQURAINIER ACQUISITION CORP | 500,000 | $5.1M | 1% |
| 35 | HAEHAEMONETICS CORP MASSPUT | 44,700 | $4.7M | 0.9% |
| 36 | QTTBQ32 BIO INC | 529,155 | $4.4M | 0.8% |
| 37 | SERSERINA THERAPEUTICS INC | 2.0M | $4.0M | 0.8% |
| 38 | DRUGBRIGHT MINDS BIOSCIENCES INC | 75,152 | $3.7M | 0.7% |
| 39 | SVRASAVARA INC | 657,104 | $3.4M | 0.6% |
| 40 | OKURONKURE THERAPEUTICS INC | 1.1M | $3.0M | 0.6% |
| 41 | ANTXAN2 THERAPEUTICS INC | 548,103 | $2.9M | 0.6% |
| 42 | IMNMIMMUNOME INC | 132,097 | $2.8M | 0.5% |
| 43 | ZBIOZENAS BIOPHARMA INC | 95,457 | $2.6M | 0.5% |
| 44 | OVIDOVID THERAPEUTICS INC | 1.0M | $2.5M | 0.5% |
| 45 | ALGSALIGOS THERAPEUTICS INC | 327,237 | $1.8M | 0.3% |
| 46 | FULCFULCRUM THERAPEUTICS INC | 481,601 | $1.8M | 0.3% |
| 47 | ALHCALIGNMENT HEALTHCARE INC | 184,424 | $1.5M | 0.3% |
| 48 | XLOXILIO THERAPEUTICS INC | 152,464 | $1.4M | 0.3% |
| 49 | EYPTEYEPOINT INC | 373,666 | $1.2M | 0.2% |
| 50 | QTIQT IMAGING HLDGS INC | 440,446 | $1.1M | 0.2% |
| 51 | IBIOIBIO INC | 904,268 | $1.1M | 0.2% |
| 52 | TELATELA BIO INC | 636,300 | $731,745 | 0.1% |
| 53 | ENVBENVERIC BIOSCIENCES INC | 330,000 | $490,050 | 0.1% |
| 54 | NMTCNEUROONE MED TECHNOLOGIES CO | 82,767 | $85,250 | 0% |
| 55 | MODDMODULAR MED INC | 26,190 | $52,380 | 0% |
Source: SEC Form 13F-HR, reporting period 2026-09-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.